COMPASS THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20_____ Debt SecuritiesIndenture • August 30th, 2024 • Compass Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledAugust 30th, 2024 Company Industry JurisdictionTHIS INDENTURE, dated as of [•], 20___, between COMPASS THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
AMENDMENT NO. 1 TO THE OPEN MARKET SALE AGREEMENTSMCompass Therapeutics, Inc. • August 30th, 2024 • Biological products, (no disgnostic substances)
Company FiledAugust 30th, 2024 IndustryThis Amendment No. 1 to the Open Market Sale AgreementSM (this “Amendment”) is entered into as of the date first written above by Compass Therapeutics, Inc., a Delaware corporation (the “Company”), and Jefferies LLC (the “Agent”), who are parties to that certain Open Market Sale AgreementSM, dated August 1, 2022 (the “Original Agreement”) relating to the offering of the Company’s Common Shares.